Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-13-365360
Filing Date
2013-09-12
Accepted
2013-09-12 16:54:01
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d593055d10ka.htm 10-K/A 396527
2 EX-23.1 d593055dex231.htm EX-23.1 1963
3 EX-31.1 d593055dex311.htm EX-31.1 7968
4 EX-32.1 d593055dex321.htm EX-32.1 3870
5 GRAPHIC g593055g15h69.jpg GRAPHIC 9405
  Complete submission text file 0001193125-13-365360.txt   424616
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52089 | Film No.: 131094633
SIC: 3841 Surgical & Medical Instruments & Apparatus